Diageo Could See Moves Monday on Berkshire Exit, Lewis Report

May 16, 2026
Diageo Could See Moves Monday on Berkshire Exit, Lewis Report

London, May 16, 2026, 22:08 BST

Diageo shares face pressure Monday with investors reacting to a late-week report on a management shake-up and a Reuters item that said Berkshire Hathaway no longer holds a stake in the Guinness maker. Diageo’s London shares finished Friday at 1,529.5 pence, rising 1.97% for the day but losing around 0.9% since the prior week’s close.

The weekend’s pause could prove important after Bloomberg said Friday that a group of top Diageo executives will exit as Chief Executive Dave Lewis works on a major overhaul. Now, investors have to figure out next week if Friday’s move up was real momentum or just some relief in an otherwise weak trading stretch.

FTSE 100 slips 1.71% as UK assets drop; Diageo bucks trend The tape was weak. The FTSE 100 lost 1.71% to end at 10,195.37 on Friday. British stocks, bonds, and sterling dropped as political jitters and rising oil prices weighed on risk appetite, Reuters said. Diageo’s move was notable for rising while the rest of the market fell.

Diageo reported May 6 that net sales for the third quarter climbed 2.3% to $4.477 billion. Organic net sales, which exclude currency and portfolio shifts, were up just 0.3%. The company kept its outlook for fiscal 2026 steady.

North America is still the weak spot. The region makes up 38% of net sales but saw a 9.4% organic sales drop for the quarter, and U.S. spirits fell 15.4%. Europe, Latin America and the Caribbean, and Africa posted solid growth. Lewis said North America is “our biggest challenge” with actions “already underway.” Investegate

Diageo’s shares have had a choppy week. The stock got a boost after its May 6 sales numbers beat estimates, but investors are still unsure how quickly CEO Lewis can fix the company’s U.S. arm. U.S. sales have taken a hit from price cuts, slow tequila sales, and volatile inventories at distributors. Reuters reported the shares gained 4.7% in mid-session after the Q3 update.

India moved in a different direction. United Spirits, Diageo’s business in the country, reported a roughly 27% jump in fourth-quarter profit as buyers favored higher-end brands. CEO Praveen Someshwar said a new Karnataka policy may “provide a fillip” to the state’s premiumisation trend, with more people switching to pricier options. Reuters

Lewis has a clearer pitch on beer. Diageo just opened its Littleconnell brewery in County Kildare last week, kicking off nearly 1 billion euros of investment in Ireland. The company said its planned second brewery in the country will back up growth for Guinness and Guinness 0.0. Lewis said demand for those brands “is surging.” Diageo

Competitive pressure has pulled back slightly. Reuters said earlier this month the failed merger between Pernod Ricard and Brown-Forman took away a looming bigger No. 2 competitor. HSBC analyst Carlos Laboy went further, calling Diageo a “poor market leader.” Reuters

The risks are clear. If U.S. demand stays sluggish, Diageo may have to cut prices more or pour extra money into its brands, which would squeeze margins ahead of any sales rebound. Rising oil and energy prices could weigh on bottle and freight costs and stretch consumer budgets. Trouble in the UK market could still pull the stock down even if the company news isn’t as bad.

This week isn’t driven by any one set piece. Investors are watching if the market accepts the new setup. Diageo’s diary has the interim dividend going out June 4. The bigger focus is still on August 6, when preliminary results and a strategy update are due. That’s when Lewis’s approach faces its main check.

Stock Market Today

  • Surge in Severe Side Effects from Illegal Peptides in Victoria Sparks Health Warnings
    May 16, 2026, 5:29 PM EDT. Victorians are experiencing serious health risks from illegal peptides, including vomiting, chest pain mimicking heart attacks, and severe skin infections requiring grafts or amputations. Emergency departments, notably Royal Melbourne Hospital, report increasing cases linked to black-market peptide use, often involving overdoses fueled by social media trends. Doctors warn these unregulated products carry risks of bacterial contamination leading to life-threatening conditions such as compartment syndrome. The Coroner's Court is investigating a Victorian death tied to growth-stimulating peptides prescribed by a practitioner. Health professionals urge caution amid a rise in experimental peptide injections among young men facing body image pressures, highlighting the dangers of unregulated substances and misuse.